Search

everythinglearnresearchcommunity

for

Search:↓

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Different jujube genotypes have varying sizes, colors, and tastes, with potential for growth in Slovakia.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Ziziphus is a versatile plant with health benefits and commercial uses.

JW0061 may be a new treatment for hair loss by promoting hair growth through WNT signaling.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Ziziphus jujube Mill extract can naturally protect corn from fungi.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

WRKY transcription factors help plants manage stress and support growth.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

JMJD3 and NF-κB activate Notch1, which is essential for skin cell movement and wound healing.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

JAK inhibitors show promise in treating difficult skin diseases.

Recent advances show zebrafish can model anemia, Alx4 affects craniofacial and hair development, and mTORC1 is crucial for retinal development.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Genetic testing is crucial for diagnosing and managing non-Herlitz junctional epidermolysis bullosa.

JAK inhibitors can enter the skin through hair follicles using a unique pathway.